Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects
Houston-based Law Firm Offers Assistance, Information to People Affected by Dangerous Tysabri
Houston, TX (PRWEB) August 2, 2008 -- Tysabri
side effects lawyers Pulaski & Middleman announce the launch of a http://www.tysabrilawsuitattorney.com [website] d...
MS Drug Tysabri Approved for Crohn's Disease
But the drug comes with serious risks, FDA notes
MONDAY, Jan. 14 (HealthDay News) -- Tysabri, a controversial drug used to treat multiple sclerosis, may also be used for patients with a moderate to severe form of another autoimmune illness, Crohn's disease, the U.S. Food and Drug Admin...
Stopping Tysabri May Worsen MS
Small study finds increase in disease-linked brain lesions
THURSDAY, Sept. 13 (HealthDay News) -- People suffering from multiple sclerosis who stopped taking the controversial drug Tysabri
experienced a resurgence of brain lesions associated with their disease, researchers report.
MS patients report greater treatment satisfaction with TYSABRI
Atlanta, Ga. May 28, 2009 Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced interim results from an ongoing, one-year longitudinal health-outcomes study in which patients reported significantly higher levels of treatment satisfaction after three infusions with TYSA...
Multiple Sclerosis drug, Tysabri banned due to neurological disorders
Tysabri, which is used in the treatment of Multiple Sclerosis (MS), has been withdrawn from market after the two patients taking the drug complained of neurological disorders. The relationship between the drug and // Progressive Multifocal Leukoencephalopathy (PML) is being researched by the scient...
Warning Issued by FDA on consumption of the drug Tysabri used to treat Multiple Sclerosis
Recently the Food and Drug Administration (FDA) issued a public health advisory to inform patients and health care // providers about the suspended marketing of Tysabri
(nataluzimab) the drug meant to treat relapsing forms of multiple sclerosis (MS) which was approved by the FDA in 2004.
PDL BioPharma Announces Second Quarter 2009 Financial Results
...approximately 50 percent of underlying product sales is in currencies other than U.S. dollars.
"We have seen significant increases in sales of tysabri
and other products in our licensing portfolio, demonstrating that these products are fulfilling the promise of the underlying humanization technology,...
Aurora Physician Recognized for Multiple Sclerosis Care
...benefits of plasma exchange for treating multiple sclerosis at the American Academy of Neurology annual meeting. In addition, his research on the drug tysabri
was published in Neurology , an American Academy of Neurology journal.
The National Multiple Sclerosis Society estimates 400,000 people in the ...
MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR
...han one-third of the patients used Avonex as index medication, while others used Copaxone (31 percent), Rebif (17 percent), Betaseron (14 percent) and tysabri
(less than 1 percent).
HealthCore, based in Wilmington, Del., is the clinical outcomes research subsidiary of WellPoint. He...
Tysabri May Treat Myelin Sheath Damage From MS
TUESDAY, April 28 (HealthDay News) -- The drug tysabri
(natalizumab) appears to regenerate and stabilize ...r 12 months of follow-up, the 62 patients who took tysabri
showed remyelination when compared to the 26 who t... "What we have seen in these MRI data suggest that tysabri
may have the capacity to repair and possibly resto...